A Phase I-Ii, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of 99mTc-Sestamibi in Pediatric Subjects

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.114.146795
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine


Related search